期刊： JOURNAL OF VIRAL HEPATITIS, 2022; 29 (6)

Co-infection with Hepatitis C virus (HCV) among HIV-positive patients leads to accelerated progression of liver disease and AIDS. Due to increased HCV......

JIF：3.209

期刊： JOURNAL OF VIRAL HEPATITIS, 2022; 29 (11)

Persons who inject drugs (PWID) have been experiencing a higher burden of new hepatitis C (HCV) due to the opioid epidemic. The greatest increases in ......

JIF：3.209

期刊： JOURNAL OF VIRAL HEPATITIS, 2022; 29 (5)

Objective This study aimed to clarify the expression of HLA-DQ and granulysin in peripheral blood T-cell subsets in patients with chronic hepatitis B ......

JIF：3.209

期刊： JOURNAL OF VIRAL HEPATITIS, 2022; 29 (9)

The study aimed to determine adjusted all-cause mortality and cause of death in persons with chronic hepatitis B virus (HBV) infection compared with a......

JIF：3.209

期刊： JOURNAL OF VIRAL HEPATITIS, 2022; 29 (9)

Alanine aminotransferase (ALT) flare remains one of the determinants of initiating antiviral therapy in children with chronic hepatitis B (CHB). Insuf......

JIF：3.209

期刊： JOURNAL OF VIRAL HEPATITIS, 2022; 29 (12)

Treatment for hepatitis C virus (HCV) with direct-acting antivirals (DAA) is advantageous over previous treatment options due to high efficacy, short ......

JIF：3.209

期刊： JOURNAL OF VIRAL HEPATITIS, 2022; 29 (12)

Patients with tuberculosis (TB) disease treated with multi-drug regimens are at risk of developing drug induced liver injury (DILI), and DILI risk mig......

JIF：3.209

期刊： JOURNAL OF VIRAL HEPATITIS, 2022; 29 (1)

Many people with chronic hepatitis C infection don't engage in treatment. To eliminate hepatitis C and avoid health inequalities therapy must be provi......

JIF：3.209

期刊： JOURNAL OF VIRAL HEPATITIS, 2022; 29 (6)

Achieving global elimination of hepatitis C virus requires a substantial scale-up of testing. Point-of-care HCV viral load assays are available as an ......

JIF：3.209

期刊： JOURNAL OF VIRAL HEPATITIS, 2022; 29 (11)

Donors with resolved hepatitis B virus (HBV) infection may be a solution for the organ shortage for kidney transplantation (KT). The purpose of this s......

JIF：3.209

期刊： JOURNAL OF VIRAL HEPATITIS, 2022; 29 (2)

Current therapeutic interventions can only suppress hepatitis B virus (HBV) replication or reduce complications without a cure. Therefore, further dev......

JIF：3.209

期刊： JOURNAL OF VIRAL HEPATITIS, 2022; 29 (8)

Hepatitis B virus (HBV) affects over 300 million people across the world and is further associated with the self-digesting process of autophagy. Accor......

JIF：3.209

期刊： JOURNAL OF VIRAL HEPATITIS, 2022; 29 (4)

People living with HIV (PLHIV) are a priority population to receive hepatitis C virus (HCV) screening and treatment. We aimed to characterize the HCV ......

JIF：3.209

期刊： JOURNAL OF VIRAL HEPATITIS, 2022; 29 (10)

Hepatitis B virus e antigen (HBeAg) loss and the appearance of antibodies to HBeAg (anti-HBe) are favourable events in the history of chronic hepatiti......

JIF：3.209

期刊： JOURNAL OF VIRAL HEPATITIS, 2022; 29 (1)

Chronic hepatitis B virus (HBV) infection affects >10% of the general population and is the leading cause of liver cirrhosis and cancer in West Afr......

JIF：3.209